Literatur

Aaby P et al.: Evidence of Increase in Mortality After the Introduction of Diphtheria-Tetanus-Pertussis Vaccine to Children Aged 6-35 Months in Guinea-Bissau: A Time for Reflection? Front in Pub Health 2018. 6:79ff. www.frontiersin.org/articles/10.3389/fpubh.2018.00079/full

Benedetti F et al.: How do placebos work? Eur J Psychotraumatol 2018. 9(Suppl 3): 1533370.

Benedetti F.: Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 2013. 93(3):1207-46

Benedetti F.: Placebo Effects: From the Neurobiological Paradigm to Translational Implications. Neuron 2014, 84(3):p623–637, 5

Benedetti F: Placebo and the New Physiology of the Doctor-Patient Relationship. Phys Rev 2013, 93(3):1207-46

Benedetti F: Teaching neurons to respond to placebos J Physiol. 2016 ; 594(19): 5647–5660 – Video-Vortrag 2016

Benn CS. Non-specific effects of vaccination in Denmark. Ugeskr Laeger 2018. 180(44)

Bradford et al.: Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes Clin Exp Vaccine Res 2015. 4: 23–45

Carvalho C et al.: Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain: December 2016. 157(12): 2766–2772

Chadwick R: Compassion: hard to define, impossible to mandate. BMJ 2015. 351:h33991

Codec CT et al.: Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface 2007. 4(17): 1119–1125

Coelho F et al.: Dynamic Modeling of Vaccinating Behavior as a Function of Individual Beliefs, PLoS Computational Biology 2009

Cohen D: Oxford vaccine study highlights pick and mix approach to preclinical research. BMJ 2018. (Clinical research ed.). 360, j5845. www.bmj.com/content/bmj/suppl/2018/01/09/bmj.j5845.DC1/cohd151217.ww1.pdf

Cohen J: Zika rewrites maternal immunization ethics. Science 2017. 357(6348)241-2

De Bree et al.: Non-specific effects of vaccines: Current evidence and potential implications. In: Seminars in immunology 2018. 39, S. 35–43

De Luca F et al.: The microbiome in autoimmune diseases. Clin Exp Immunol. 2019. 195(1):74-85

Estes ML et al.: Maternal immune activation: Implications for neuropsychiatric disorders. Science 2017. 353(6301):772-7. http://science.sciencemag.org/content/353/6301/772.long

Frattarelli D: Adverse drug reactions and avalanches: Life at the edge of chaos. J Clin Pharmacol 2005. 45:866-871

Frost E et al.: The brain’s reward circuity regulates immunity. Nature Medicine 2016. 22(8)835-6

Halabi S et al.: Legal Complexities of Global Vaccine Compensation Systems. JAMA 2017. 317(18):1912

Hayat G et al.: Nanovaccine: A novel approach in immunization. Journal of cellular physiology 2019. 11.01.2019, doi 10.1102 / jcp.28120

Higgins J et al.: Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 2016. 355, i5170. www.bmj.com/content/355/bmj.i5170

Jäger H: Grippeimpfung in der Schwangerschaft. DHZ 2013. 9:42–46

Jäger H: Schwangere gegen »Grippe« impfen? DHZ 2019. 71(1):48–52

Kandasamy R et al.: Non-specific immunological effects of selected routine childhood immunisations: systematic review. BMJ 2016. 355, i5225. www.bmj.com/content/355/bmj.i5225

Kipnis J: Multifaceted interactions between adaptive immunity and the central nervous system. Science 2016. 353(6301) 766-71

Lee M: Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation. Vaccine 2016. 34 2055–2061

Lei Y et al.: Application of built-in adjuvants for epitope-based vaccines. Peer J 2019. 6: e6185.

Leroux-Roels G: Unmet needs in modern vaccinology adjuvants to improve the immune response 2010. Vaccine 2010. 28S:C25-C36

Liblau RS (): Put to sleep by immune cells. Nature 2018. 562(7725):46-48

Loxterham D: relationships – the water that doctors breathe, BMJ 2015, 351:h4185

Mastroianni A et al : Legal Complexities of Global Vaccine Compensation Systems, JAMA 2017, 317(18):1911-1912

Mogensen SW et al.: The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young Infants in an Urban African Community: A Natural Experiment. Ebio 2017. 17:192-198

Nolte SH: Impfen im Spannungsfeld zwischen Zielerkrankungen und den spezifischen Auswirkungen auf die allgemeine Gesundheit. Päd Praxis 2018. 90:1-7

Peng H: Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum Vaccin Immunother 2015. 11(2): 477–488

Reed SG: Key roles of adjuvants in modern vaccines. Nature Medici 2013. 19(2) 1597-1608

Relton C et al.: Rethinking pragmatic randomised controlled trials: introducing the »cohort multiple randomised controlled trial" design. BMJ 2010. 340:963-967

Restoring invisible & abandoned Trials (RIAT): Untersuchte Studien: https://restoringtrials.org/riat-studies

Sarkanen T et al.: Narcolepsy Associated with Pandemrix Vaccine. Current Neurology and Neuroscience Reports. Curr Neurol Neurosci Rep 2018. 18: 43

Schmidt ST et al.: Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Pharmaceutics 2016. 8, 7

Schulte-Uebbing C: Aluminium als endokriner Disruptor und mögliche (Teil-)Ursache des hormonabhängigen Mamma Ca. Gyn 2017. 1

Shah R et al.: The impact of size on particulate vaccine adjuvant. Nanomedicine 2014. 9(17): 2671–2681

Shaw C et al.: Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy? Immunotherapy 2014. 6 (10) 1055–1071

Shaw C: Aluminum as a CNS and Immune System Toxin Across the Life Span. Adv Exp Med Biol 2018. 1091:53–83

Watad A et al.: The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld›s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol 2018. 37(2):483–493

Wen Y et al.: Alum: an old dog with new tricks. Emerging Microbes and Infections 2016. 5, e25

Yung CF: Non-specific effects of childhood vaccines. BMJ 2016. (Clinical research ed.) 355, i5434. www.bmj.com/content/355/bmj.i5434

« Zurück zum Artikel